SCHEMBL21542040

SCHEMBL21542040

CC(C)Nc1nc(NCc2ccccc2S(C)(=O)=O)c2ncccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.46
ACHE P22303 3/20 0.46
APP P05067 2/20 0.46
NPR1 P16066 5/20 0.41
PIP4K2C Q8TBX8 1/20 0.41
JAK1 P23458 1/20 0.40
JAK3 P52333 1/20 0.40
STAT6 P42226 1/20 0.38
PTK2 Q05397 2/20 0.37
PTK2B Q14289 2/20 0.37
TLR8 Q9NR97 2/20 0.36
TLR7 Q9NYK1 2/20 0.36
P2RX7 Q99572 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
EGFR P00533 1/20 0.36
CCNT1 O60563 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
CDK7 P50613 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30092953 0.85 ACHE (0.65) BCHEACHEAPPNPR1
SCHEMBL20399736 0.85 ACHE (0.65) BCHEACHEAPPNPR1
SCHEMBL21542016 0.83 BCHE (0.46) BCHEACHEAPPNPR1PIP4K2C
SCHEMBL21542032 0.82 BCHE (0.52) BCHEACHEAPPNPR1PIP4K2C
SCHEMBL21567419 0.80 CDK1 (0.48) BCHEACHEAPPNPR1PIP4K2C
SCHEMBL21542022 0.79 LRRK2 (0.46) BCHEACHEAPPNPR1ADORA2A
SCHEMBL20400138 0.79 BCHE (0.45) BCHEACHEAPPNPR1PIP4K2C
SCHEMBL21542002 0.72 APP (0.53) BCHEACHEAPPNPR1PIP4K2C
SCHEMBL30092878 0.72 BCHE (0.53) BCHEACHEAPPNPR1PIP4K2C
SCHEMBL21567262 0.72 BCHE (0.53) BCHEACHEAPPNPR1PIP4K2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2026-02-10 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2022-12-06 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds CBR1, CBR3, COX6C BCHE 2784/4885ACHE 2483/4885APP 4837/4885
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS PWWP2B, WARS1, PNPO BCHE 3860/4885ACHE 1710/4885APP 3897/4885
US-20190345157-A1 COMPOUNDS ABCB11, LTC4S, AQP1 BCHE 632/4885ACHE 297/4885APP 2829/4885
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds P2RX5, PNPO, P2RX3 BCHE 3579/4885ACHE 1142/4885APP 4242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.